Rangeley Capital, LLC
Q2 2025 13F-HR Holdings
Net value change ($000)
—
New positions
68
Sold out positions
0
Turnover %
100.0%
Sector allocation + QoQ delta (equities-only)
Snapshot: Change Analysis
Compared to previous filing: —
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| Sage Therapeutics, Inc. | 6,658 | — |
| DK | 6,629 | — |
| ARVN | 5,114 | — |
| CLMT | 5,026 | — |
| PRTA | 4,342 | — |
| KROS | 3,810 | — |
| SGRY | 3,692 | — |
| WOW | 3,244 | — |
| FLL | 3,230 | — |
| iTeos Therapeutics, Inc. | 3,012 | — |
Top Reduces (Value $000, Stocks/ETFs)
| — |
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000):
4,098
(4.9% of total reported value)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|